home All News open_in_new Full Article

Boehringer Ingelheim and Tessellate Bio partner to develop first

Ingelheim, Germany and Amsterdam, the Netherlands, 23 April 2025 – Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration and global license agreement. Jointly the partners will focus on the development of first-in-class, oral precision treatments for people living with […]


today 5 h. ago attach_file Economics

attach_file Politics
attach_file Events
attach_file Economics
attach_file Transport
attach_file Events
attach_file Other
attach_file Culture
attach_file Other
attach_file Sport
attach_file Society
attach_file Economics
attach_file Other
attach_file Events
attach_file Events
attach_file Society
attach_file Other
attach_file Events
attach_file Economics
attach_file Other
attach_file Sport


ID: 1635626747
Add Watch Country

arrow_drop_down